JAX Interview: Humanized mice help the development and translation of cellular immune drugs

Dr.
Jieling Yang of the 6th IGC Immune Gene and Cell Therapy Conference in Beijing shared the leading application practice
of humanized mouse models in helping the development and translation of cellular immune drugs.
At that time, Jackson Aite also set up a booth on the spot, looking forward to your visit
.
Presentation Time:
Lecture Venue:
Speaker:
Speaker Introduction:

---

Q: With the development of the domestic biomedical industry, the animal model track is also particularly hot
.
As a leader in mouse models, JAX has been working on the study of human diseases
using mice as models.
Can you briefly share how to understand the impact of differences between mice and humans on research, or can the results of mouse-based research represent the real situation of human disease?

---

Q: Seeing that your talk is humanized mice, in your opinion, humanized mice as a model can help solve the important problems of current cellular immunotherapy drugs in preclinical research and transformation process?

---

Q: NK cells are one of the frontiers of tumor immunity research and development, including CAR-NK and various drugs
that directly or indirectly act on NK cells.
Is there any solution for jax's humanized mouse model for this piece?

---

Q: China's biopharmaceutical industry is developing rapidly, and the field of tumor immunology is only one of the corners
.
If you look at the whole industry, can you tell us about the unique disease models or resources of Jackson mice that can help drug development?